Vir Biotechnology, Inc. / Fundamentals
Income statement
- Net revenue
€15.24M - Cost of goods sold
€639.21K - Gross profit
€13.66M - SG&A expenses
€84.66M - R&D expenses
€443.94M - EBITDA
-€501.81M - D&A
€7.42M - EBIT
-€509.40M - Interest expenses
€0.00 - EBT
-€471.86M - Tax expenses
-€54.05K - Net income
-€472.10M
Cash flow statement
- Net deferred tax
-€2.22M - Non-cash items
€15.26M - Changes in working capital
€422.14K - Operating cash flow
-€392.49M - Capex
€7.66M - Other investing cash flow
€3.17M - Net investing cash flow
€379.76M - Total cash dividends paid
€0.00 - Issuance of common stock
€1.57M - Debt repayment
-€34.32K - Other financing cash flow
€1.91M - Net financing cash flow
€3.38M - Foreign exchange effects
€0.00 - Net change in cash
-€3.89M - Cash at end of period
€262.79M - Free cash flow
-€384.83M
Balance sheet
- Cash and cash equivalents
€256.82M - Cash and short-term investments
€589.42M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€41.82M - Total current assets
€631.24M - Property, plant & equipment
€107.81M - Goodwill
€14.53M - Intangible assets
€6.86M - Long-term investments
€245.47M - Other non-current assets
€17.28M - Total non-current assets
€391.96M - Total assets
€1.02B - Accounts payable
€10.50M - Short-term debt
€0.00 - Other current liabilities
€70.92M - Total current liabilities
€90.09M - Long-term debt
€80.14M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€40.03M - Total non-current liabilities
€120.17M - Total liabilities
€210.26M - Common stock
€12.01K - Retained earnings
-€850.89M - Other equity
-€1.91M - Total equity
€812.93M - Total liabilities and shareholders' equity
€1.02B
Company information
- Market capitalization
€609.60M - Employees
408 - Enterprise Value
€548.27M
Company ratios
- Gross margin
-
89.6% Much better than peer group: -66.1% - EBITDA margin
-
-3,292.8% Much worse than peer group: -3,206.7% - EBIT margin
-
-3,342.6% Much better than peer group: -3,523.0% - EBT margin
-
-3,096.2% Much better than peer group: -3,948.0% - Net margin
-
-3,097.8% Much better than peer group: -3,479.1% - ROE
-
-58.1% Much better than peer group: -119.9% - ROA
-
-46.1% Much better than peer group: -391.9% - Asset turnover
-
1.5% Worse than peer group: 14.3% - FCF margin
-
-2,625.7% Much better than peer group: -2,728.4% - FCF yield
-65.6% - Efficiency ratio
3,392.8% - Net sales per employee
-
€37.35K - Net income per employee
-
-€1.16M